Search - tctmd.com

Displaying 21 - 40 of 50

Sort: Relevancy | Date

Presentation TVT 2022

EFFICACY AND SAFETY OUTCOMES OF CEREBRAL EMBOLIC PROTECTION DEVICES DURING TRANSCATHETER AORTIC VALVE REPLACEMENT: AN UPDATED META-ANALYSIS

Presenter: Arpanjeet Kaur

June 08, 2022

Presentation TVT 2022

Pattern of Hospital-Level Use of Cerebral Embolic Protection for Transcatheter Aortic Valve Replacement and Association with Outcomes

Presenter: AAMER UBAID

June 08, 2022

Presentation TVT 2021

A Novel Embolic Protection System (Filterlex)

Presenter: Haim Danenberg

July 22, 2021

Presentation TVT 2021

Does Medical Therapy Make a Difference: Anti-Platelet and Anti-Thrombotic Therapy After TAVR

Presenter: George Dangas

July 21, 2021

Presentation TVT 2021

Cerebral Embolic Protection: Updates From the Clinical Trials and Future Directions

Presenter: Samir Kapadia

July 21, 2021

Presentation TVT 2021

Does LAA Occlusion Make Sense in TAVR AF Patients: Updates From WATCH TAVR

Presenter: Amar Krishnaswamy

July 21, 2021

News Conference News TVT 2021

TAVI Outcomes Similar in Low-Risk Bicuspid, Tricuspid Aortic Stenosis at 1 Year

Todd Neale

July 20, 2021

News Conference News TVT 2020

Stroke in TAVR: Full Impact of Embolic Devices, Anticoagulants, Technique Remain Unclear

Todd Neale

June 25, 2020

Presentation TVT 2019

Operator and Institutional Requirements for PFO Closure for Secondary Prevention of Paradoxical Embolic Stroke

Presenter: Zahid Amin

June 14, 2019

Presentation TVT 2019

PFO Closure for Secondary Prevention of Paradoxical Embolic Stroke: Randomized Trial Synthesis

Presenter: Fabian Nietlispach

June 14, 2019

News Conference News TVT 2019

Real-world Stroke With TAVR: TVT Registry Insights Rekindle Cerebral Protection Debate

Shelley Wood

June 13, 2019

Presentation TVT 2019

Cerebral Embolic Protection for TAVR With TriGuard 3: Updates From the REFLECT Clinical Trial

Presenter: Tamim Nazif

June 13, 2019

Presentation TVT 2019

Comprehensive Review of the Sentinel Cerebral Embolic Protection Program

Presenter: Julia Seeger

June 13, 2019

Presentation TVT 2019

Status Updates on the Next Generation of Cerebral Protection Devices

Presenter: Giora Weisz

June 13, 2019

Presentation TVT 2017

The SENTINEL Trial: Safety and Effectiveness of Cerebral Embolic Protection During TAVR

Presenter: Axel Linke, Jeffrey J. Popma, Susheel Kodali

June 15, 2017

News Conference News TVT 2017

Embolic Protection During TAVR Reduces Stroke Risk, Single-Center Study Shows

Michael O'Riordan

June 15, 2017

Presentation TVT 2017

A Randomized Trial of Cerebral Embolic Protection in Patients Undergoing Surgical Aortic Valve Replacement (SAVR)

Presenter: Alexandra J. Lansky, Nicolas M. Van Mieghem, Michael J. Mack

June 15, 2017

Presentation TVT 2017

A Description of the U.S. REFLECT Randomized Clinical Trial

Presenter: Jeffrey W. Moses

June 15, 2017

Presentation TVT 2017

Device Design Features and Findings From EU Clinical Trials

Presenter: Joachim Schofer

June 15, 2017

Presentation TVT 2017

A Propensity Score Analysis of Matched TAVR Patients With and Without Cerebral Protection

Presenter: Jochen Wöhrle

June 15, 2017

Advertisement

EFFICACY AND SAFETY OUTCOMES OF CEREBRAL EMBOLIC PROTECTION DEVICES DURING TRANSCATHETER AORTIC VALVE REPLACEMENT: AN UPDATED META-ANALYSIS

Pattern of Hospital-Level Use of Cerebral Embolic Protection for Transcatheter Aortic Valve Replacement and Association with Outcomes

A Novel Embolic Protection System (Filterlex)

Does Medical Therapy Make a Difference: Anti-Platelet and Anti-Thrombotic Therapy After TAVR

Cerebral Embolic Protection: Updates From the Clinical Trials and Future Directions

Does LAA Occlusion Make Sense in TAVR AF Patients: Updates From WATCH TAVR

TAVI Outcomes Similar in Low-Risk Bicuspid, Tricuspid Aortic Stenosis at 1 Year

Stroke in TAVR: Full Impact of Embolic Devices, Anticoagulants, Technique Remain Unclear

Operator and Institutional Requirements for PFO Closure for Secondary Prevention of Paradoxical Embolic Stroke

PFO Closure for Secondary Prevention of Paradoxical Embolic Stroke: Randomized Trial Synthesis

Real-world Stroke With TAVR: TVT Registry Insights Rekindle Cerebral Protection Debate

Cerebral Embolic Protection for TAVR With TriGuard 3: Updates From the REFLECT Clinical Trial

Comprehensive Review of the Sentinel Cerebral Embolic Protection Program

Status Updates on the Next Generation of Cerebral Protection Devices

The SENTINEL Trial: Safety and Effectiveness of Cerebral Embolic Protection During TAVR

Embolic Protection During TAVR Reduces Stroke Risk, Single-Center Study Shows

A Randomized Trial of Cerebral Embolic Protection in Patients Undergoing Surgical Aortic Valve Replacement (SAVR)

A Description of the U.S. REFLECT Randomized Clinical Trial

Device Design Features and Findings From EU Clinical Trials

A Propensity Score Analysis of Matched TAVR Patients With and Without Cerebral Protection

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content